drugset
drugset / Trial / NCT00826098

Platelet Rich Plasma (PRP) in Total Knee Replacement

NCT00826098 ↗

Phase 4 Completed 70 enrolled Exactech
RandomizedParallel-groupSingle-blindTreatment

Summary

Clinical study to evaluate the effect of platelet rich plasma (PRP), a derivative of a patient's whole blood, on short-term patient outcomes following total knee replacement (TKR).

Timeline

Start
2008-12
Primary completion
2011-06
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified — —

Indications

osteoarthritis